As a core component of the COPII complex, SEC13 interacts with Sec31A to form the outer layer of vesicles mediating ER-to-Golgi transport . Key findings include:
Cargo Selection: Regulates export of proteins like CFTR. Silencing SEC13 stabilizes CFTR, reducing degradation and improving ER exit .
ER Stress Response: Required for proper ER-Golgi intermediate compartment (ERGIC) recycling and degradation pathways .
SEC13 integrates into NPCs to facilitate nucleo-cytoplasmic transport. Studies reveal:
NPC Dynamics: Shuttles between cytoplasmic and nuclear pools via active transport, with a nuclear localization signal (NLS) .
NPC Stability: Mutations disrupting NPC function (e.g., nup107 in zebrafish) phenocopy SEC13-related retinal defects, emphasizing its NPC-specific role .
SEC13 interacts with diverse complexes, as shown in human bronchial epithelial (HBE) cell studies:
SEC13 H/− mice exhibit:
Reduced MHC I/II Expression: Impaired antigen presentation to T cells .
Cytokine Imbalance: Low IFN-γ/IL-6 and elevated TGF-β, indicative of a pro-immunosuppressive profile .
Neuropathies: Mutations in SEC13 or interacting WD-repeat proteins cause severe peripheral neuropathies .
Cystic Fibrosis (CFTR): SEC13 levels modulate CFTR stability, suggesting therapeutic potential in CF .
R&D Systems’ SEC13 antibody (AF9055) detects:
Protein SEC13 homolog, SEC13-like protein 1, SEC13-related protein, SEC13, D3S1231E, SEC13L1, SEC13R, npp-20.
MGSSHHHHHH SSGLVPRGSH MVSVINTVDT SHEDMIHDAQ MDYYGTRLAT CSSDRSVKIF DVRNGGQILI ADLRGHEGPV WQVAWAHPMY GNILASCSYD RKVIIWREEN GTWEKSHEHA GHDSSVNSVC WAPHDYGLIL ACGSSDGAIS LLTYTGEGQW EVKKINNAHT IGCNAVSWAP
AVVPGSLIDH PSGQKPNYIK RFASGGCDNL IKLWKEEEDG QWKEEQKLEA HSDWVRDVAW APSIGLPTST IASCSQDGRV FIWTCDDASS NTWSPKLLHK FNDVVWHVSW SITANILAVS GGDNKVTLWK ESVDGQWVCI SDVNKGQGSV SASVTEGQQN EQ.
SEC13 functions as a critical component of the coat complex II (COPII) system, specifically serving as a cage assembly factor. Unlike many other trafficking proteins with singular functions, SEC13 serves as a master regulator coordinating information flow from the genome to the proteome to facilitate spatial covariant features in human cells . The protein's multifunctional capacity enables it to simultaneously participate in multiple cellular processes, from chromatin organization to protein trafficking. Research indicates that SEC13 is simultaneously associated with multiple protein complexes that facilitate different features of a continuous program including chromatin organization, transcription, translation, trafficking, and degradation steps .
Unlike other COPII components, SEC13 demonstrates unique regulatory capabilities in protein trafficking and degradation pathways. Specifically, reduction of SEC13 expression decreases the ubiquitination and degradation of both wild-type and F508del variant cargo proteins such as cystic fibrosis transmembrane conductance regulator (CFTR) . This reduction leads to a striking increase in fold stability, suggesting that SEC13 critically influences the differentiation between export and degradation processes. This occurs primarily at the ER Golgi intermediate compartment (ERGIC) associated recycling and degradation step linked to COPI exchange . These distinct functions highlight SEC13's specialized role compared to other COPII components.
SEC13 demonstrates remarkable versatility in its protein interactions, associating simultaneously with multiple protein complexes that facilitate different aspects of cellular function. These include complexes involved in:
Chromatin organization
Transcriptional regulation
Translation processes
Protein trafficking mechanisms
Protein degradation pathways
Each of these associations is differentially sensitive to SEC13 levels, allowing SEC13 to function as a coordinator of information flow from the genome to the proteome . This wide-ranging association network positions SEC13 as a central hub in cellular information processing and protein management systems.
When designing experiments to study SEC13 function, researchers typically employ several approaches to modulate SEC13 expression:
RNA Interference (RNAi):
siRNA transfection targeting SEC13 mRNA
shRNA stable expression systems
CRISPR interference (CRISPRi) for transcriptional repression
Overexpression Systems:
Transient transfection with SEC13 expression vectors
Stable cell lines with inducible SEC13 expression
Viral delivery systems for hard-to-transfect cells
When modulating SEC13 expression, it is critical to monitor the differential effects on its multiple associated protein complexes, as research shows these complexes respond with varying sensitivity to changes in SEC13 levels . Quantitative western blotting coupled with co-immunoprecipitation assays can help determine the threshold levels at which different SEC13 functions are affected.
To accurately measure changes in protein trafficking associated with SEC13 manipulation, researchers should employ a multi-faceted approach:
Quantitative Trafficking Assays:
Pulse-chase experiments with fluorescently labeled cargo proteins
Live-cell imaging with selective markers for COPII vesicles
RUSH (Retention Using Selective Hooks) system to synchronize cargo protein release
Molecular Analysis:
Ubiquitination analysis of cargo proteins such as CFTR
Protein stability measurements through cycloheximide chase experiments
Co-localization studies with markers of the ER, ERGIC, and Golgi compartments
Based on research findings, particular attention should be paid to the ERGIC-associated recycling and degradation step linked to COPI exchange, as this appears to be a critical point where SEC13 influences the decision between export and degradation of cargo proteins . When analyzing results, researchers should account for the multifunctional nature of SEC13 and ensure controls are in place to distinguish direct trafficking effects from secondary consequences related to its other cellular roles.
The selection of appropriate model systems for SEC13 research depends on the specific aspects of its function being investigated:
Cellular Models:
| Model Type | Advantages | Best Applications |
|---|---|---|
| HEK293 cells | Highly transfectable, express many trafficking components | Initial mechanistic studies, protein interaction analysis |
| Epithelial cell lines | Polarized trafficking, physiologically relevant | Transport of membrane proteins, spatial organization |
| Primary human cells | Native expression levels, physiological regulation | Validation of findings from cell lines, disease relevance |
Disease Models:
Cystic fibrosis cellular models expressing F508del CFTR mutation are particularly valuable, as SEC13 has demonstrated significant effects on CFTR stability when modulated
Patient-derived organoids can provide insights into SEC13's role in tissue-specific contexts
When selecting a model system, researchers should consider that SEC13's diverse functions may be differentially represented across cell types. Evidence suggests that SEC13 serves as a master regulator coordinating information flow from genome to proteome across various cellular compartments, so the ideal model system should maintain these regulatory networks intact .
SEC13's role in coordinating information flow from genome to proteome involves a sophisticated network of interactions spanning multiple cellular compartments. This coordination occurs through:
Chromatin Association:
SEC13 participates in chromatin organization processes, potentially influencing gene accessibility and expression patterns that determine which proteins will be synthesized .
Transcriptional Coupling:
By associating with transcriptional machinery, SEC13 may help couple the process of gene expression to downstream events in the protein production pathway .
Translation-Trafficking Integration:
SEC13 simultaneously participates in protein synthesis and trafficking pathways, potentially serving as a feedback mechanism that adjusts translation rates based on trafficking capacity .
Compartmental Communication:
As a component of multiple protein complexes, SEC13 may facilitate communication between cellular compartments, ensuring coordinated responses to changes in cellular state or environmental conditions .
This multi-level involvement positions SEC13 as an integrator that helps maintain proteostasis by balancing production, trafficking, and degradation processes. The finding that different cellular processes show differential sensitivity to SEC13 levels suggests a mechanism by which cells can fine-tune their response to varying conditions through modulation of this single regulator .
SEC13's role in CFTR regulation has profound implications for cystic fibrosis research:
Enhanced Stability of Mutant CFTR:
Research has shown that reduction of SEC13 expression decreases the ubiquitination and degradation of both wild-type and F508del variant CFTR, leading to a striking increase in fold stability . This is particularly significant for the F508del mutation, which typically results in protein misfolding and enhanced degradation.
Potential Therapeutic Target:
The unique position of SEC13 at the intersection of trafficking and degradation pathways makes it a potential therapeutic target. By modulating SEC13 function or expression, it may be possible to shift the balance away from degradation toward successful trafficking of mutant CFTR to the plasma membrane.
Mechanistic Insights:
The finding that SEC13 critically influences the differentiation between export and degradation processes at the ERGIC provides new mechanistic insights into how cells make quality control decisions about membrane proteins . This understanding could inform the development of more targeted approaches to rescue mutant CFTR.
Broader Applications:
The principles learned from studying SEC13's role in CFTR regulation may extend to other membrane protein trafficking disorders, potentially expanding the therapeutic relevance beyond cystic fibrosis.
The research indicates that SEC13's effects on CFTR are linked to its role in COPII cage assembly particularly at the ERGIC-associated recycling and degradation step . This specificity offers a potential advantage for therapeutic interventions that could be designed to target this particular function of SEC13 without disrupting its other cellular roles.
Variations in SEC13 expression have multifaceted effects on cellular proteostasis due to SEC13's involvement in multiple protein complexes and cellular processes:
Differential Sensitivity:
Research indicates that different cellular processes exhibit varying degrees of sensitivity to SEC13 levels . This graduated response enables cells to prioritize certain functions when SEC13 availability is limited, potentially serving as an adaptive mechanism.
Trafficking-Degradation Balance:
Changes in SEC13 expression significantly impact the balance between protein trafficking and degradation. Specifically, reduction of SEC13 expression has been shown to decrease ubiquitination and degradation of certain cargo proteins, suggesting that modulation of SEC13 can shift the cellular preference between recycling and elimination of proteins .
Compartmental Organization:
SEC13's role in maintaining the architecture of cellular compartments means that alterations in its expression can influence the spatial organization of the endomembrane system. This has implications for the efficiency of protein trafficking and quality control mechanisms.
Stress Response Integration:
As a regulator coordinating information flow from genome to proteome, SEC13 likely plays a role in integrating stress responses across different cellular compartments. Changes in its expression may therefore affect the cell's ability to adapt to environmental challenges or internal perturbations.
The observation that SEC13 serves as an "unanticipated master regulator coordinating information flow from the genome to the proteome" suggests that its expression levels must be precisely controlled to maintain optimal proteostasis. Disruptions to this regulation could potentially contribute to diseases characterized by protein misfolding or trafficking defects.
Visualizing SEC13-dependent trafficking events requires specialized techniques that capture both the spatial and temporal aspects of this dynamic process:
Advanced Microscopy Approaches:
Super-resolution microscopy (STORM, PALM, or SIM) to resolve individual COPII vesicles and cage structures
Lattice light-sheet microscopy for extended live-cell imaging with reduced phototoxicity
Correlative light and electron microscopy (CLEM) to connect fluorescence signals with ultrastructural details
Molecular Probes and Reporters:
SEC13-fluorescent protein fusions (ensuring functionality is preserved)
Split fluorescent protein systems to detect SEC13 interactions with other COPII components
Cargo-specific reporters that change spectral properties upon trafficking progression
Quantitative Analysis Methods:
Automated tracking of vesicle formation and movement
Fluorescence recovery after photobleaching (FRAP) to measure assembly dynamics
Fluorescence correlation spectroscopy to analyze SEC13 molecular mobility
When implementing these techniques, special attention should be paid to the ERGIC compartment, as research has identified this as a critical site where SEC13-dependent decisions between export and degradation occur . Dual-color imaging with markers for both the COPII and COPI systems can help elucidate the hand-off between these coat complexes at the ERGIC, which appears to be particularly sensitive to SEC13 levels.
Designing experiments to distinguish between SEC13's multiple cellular roles requires careful planning and specialized approaches:
Domain-Specific Mutants:
Create SEC13 variants with mutations in specific functional domains to selectively disrupt individual roles while preserving others. This approach can help delineate which domains are essential for each cellular function.
Temporal Control Systems:
Rapid induction or degradation systems (e.g., auxin-inducible degron)
Optogenetic control of SEC13 recruitment to specific compartments
Temperature-sensitive variants to allow acute functional disruption
Compartment-Specific Analysis:
| Compartment | Analysis Technique | Key Measurements |
|---|---|---|
| Nucleus | ChIP-seq or CUT&RUN | SEC13 chromatin association patterns |
| ER-to-Golgi | Vesicle budding assays | COPII assembly kinetics |
| ERGIC | Immunoisolation | Cargo ubiquitination status |
| Global | Proteomics | Differential protein complex association |
Rescue Experiments:
Use targeted rescue approaches where SEC13 expression is restricted to specific compartments using localization signals. This can determine where SEC13 function is most critical for a given cellular process.
When interpreting results, researchers should consider that the effects seen after SEC13 manipulation may reflect the complex interplay between its multiple roles. The finding that SEC13 serves as a master regulator coordinating information flow across cellular compartments suggests that perturbations in one function might indirectly affect others through feedback mechanisms.
Analyzing SEC13 interactome data requires specialized approaches to account for its multiple cellular roles and complex interaction network:
Data Collection Considerations:
Use multiple complementary techniques (affinity purification-MS, proximity labeling, Y2H screens)
Include appropriate controls for each cellular compartment where SEC13 functions
Consider native versus overexpression conditions carefully, as interaction patterns may differ
Analytical Framework:
Categorize interactions by cellular compartment and function
Assess interaction stability (transient vs. stable) through quantitative measures
Analyze condition-dependent interactions (e.g., stress, cell cycle phase)
Specialized Analytical Approaches:
Network analysis to identify interaction hubs and modules
Comparative interactomics across different expression levels of SEC13
Integration with functional data from genetic screens
Interpretation Guidelines:
Focus on interactions that explain SEC13's coordinating role between cellular processes
Look for protein complexes with differential sensitivity to SEC13 levels
Identify interactions at the ERGIC that might explain SEC13's role in determining cargo fate
Recent research has demonstrated that SEC13 is simultaneously associated with multiple protein complexes that facilitate different features of cellular processes from chromatin organization to protein degradation . When analyzing interactome data, special attention should be paid to interactions that connect these diverse functions, as these may represent key nodes in SEC13's role as a master regulator coordinating information flow from the genome to the proteome.
Findings about SEC13 function provide valuable insights into various human disease mechanisms:
Protein Trafficking Disorders:
SEC13's critical role in COPII cage assembly and its influence on the fate of cargo proteins like CFTR directly connects to diseases caused by protein trafficking defects. Research showing that reduction of SEC13 expression decreases ubiquitination and degradation of F508del CFTR provides a mechanistic link to cystic fibrosis pathophysiology.
Neurological Disorders:
Many neurodegenerative diseases involve protein misfolding and aggregation. SEC13's role in coordinating protein quality control decisions at the ERGIC may offer insights into why certain misfolded proteins escape degradation in these conditions.
Cancer Biology:
The coordination of information flow from genome to proteome by SEC13 may be relevant to understanding how cancer cells rewire their proteostasis networks to support altered growth patterns. Changes in SEC13 expression or function could potentially contribute to the altered protein trafficking seen in many cancer types.
Developmental Disorders:
Given SEC13's involvement in fundamental cellular processes, alterations in its function could contribute to developmental abnormalities. Its role in maintaining proper endomembrane architecture may be particularly relevant to understanding conditions affecting highly secretory cell types.
When investigating disease mechanisms related to SEC13, researchers should consider both direct effects on protein trafficking and the broader implications of disrupting a master regulator that coordinates multiple cellular processes . The differential sensitivity of various cellular functions to SEC13 levels suggests that even subtle changes in its expression could have complex, context-dependent effects on disease pathogenesis.
Several therapeutic strategies could potentially target SEC13-dependent pathways with precision:
Modulation of SEC13 Expression:
Antisense oligonucleotides or siRNA to partially reduce SEC13 levels
Small molecule enhancers of SEC13 expression for conditions requiring increased trafficking capacity
Targeted protein degradation approaches (PROTACs) for selective SEC13 reduction
Pathway-Specific Interventions:
| Target Pathway | Therapeutic Approach | Potential Applications |
|---|---|---|
| COPII cage assembly | Small molecules that modify SEC13 incorporation into the cage | Rescue of trafficking-deficient proteins |
| ERGIC quality control | Modulators of the ERGIC-associated recycling step | Reduction of excessive protein degradation |
| SEC13 protein interactions | Peptide mimetics that compete for specific binding sites | Selective disruption of disease-relevant interactions |
Context-Dependent Approaches:
Given SEC13's role as a master regulator coordinating information flow from the genome to the proteome , therapeutic strategies might need to be context-dependent, targeting specific tissues or cellular states where intervention would be most beneficial.
Combinatorial Strategies:
For complex conditions like cystic fibrosis, combining SEC13-targeted approaches with existing therapies might yield synergistic benefits. For example, partially reducing SEC13 expression to decrease F508del CFTR degradation while simultaneously administering CFTR correctors could potentially enhance therapeutic efficacy.
When developing these strategies, careful consideration must be given to the potential consequences of disrupting SEC13's multiple functions. The observation that different cellular processes show differential sensitivity to SEC13 levels suggests the possibility of a therapeutic window where beneficial effects on one pathway could be achieved without significantly disrupting others.
Variations in SEC13 may significantly contribute to individual differences in disease manifestation through several mechanisms:
Expression Level Variations:
Research has shown that different cellular processes exhibit differential sensitivity to SEC13 levels . Even subtle variations in SEC13 expression between individuals could therefore influence which cellular functions are preserved or compromised in disease states.
Genetic Modifiers:
Polymorphisms in SEC13 or its regulatory regions could alter its expression or function
Variations in SEC13-interacting proteins might modify its effects on specific pathways
Epigenetic differences affecting SEC13 expression could contribute to disease heterogeneity
Tissue-Specific Effects:
Because SEC13 coordinates processes from chromatin organization to protein degradation , its impact likely varies across tissue types depending on their specific proteostasis requirements. This could explain why certain diseases affect some tissues more severely than others despite involving proteins expressed throughout the body.
Environmental Interactions:
SEC13's role as a master regulator coordinating information flow from the genome to the proteome positions it as a potential mediator of gene-environment interactions. Individual variations in SEC13 function might influence how environmental stressors affect cellular proteostasis.
Therapeutic Response Prediction:
Understanding an individual's SEC13 status could potentially help predict their response to therapies targeting protein trafficking or degradation. For example, in cystic fibrosis, variations in SEC13 might influence the efficacy of treatments aimed at rescuing mutant CFTR from degradation.
When studying disease cohorts, researchers should consider incorporating SEC13 expression analysis and genetic profiling to identify potential correlations with disease severity or progression. The complex, multi-functional nature of SEC13 suggests that its contribution to disease heterogeneity may be equally multifaceted, requiring comprehensive assessment approaches.
Several cutting-edge technologies hold promise for deepening our understanding of SEC13's complex cellular roles:
Spatially Resolved Omics:
Spatial transcriptomics to map SEC13-dependent gene expression patterns across cellular compartments
Spatial proteomics to track protein distribution changes in response to SEC13 modulation
In situ cryo-electron tomography to visualize native COPII cage structures at molecular resolution
Advanced Functional Genomics:
CRISPR base editing for precise modification of SEC13 regulatory elements
Single-cell multi-omics to correlate SEC13 expression with transcriptome, proteome, and cellular phenotypes
Perturb-seq approaches to systematically assess genetic interactions with SEC13
Artificial Intelligence Integration:
Deep learning analysis of SEC13-dependent vesicle dynamics
AI-assisted protein structure prediction to model SEC13 interactions
Machine learning classification of SEC13-dependent cellular phenotypes
Protein Engineering Approaches:
Optogenetic variants of SEC13 for spatiotemporal control of function
Engineered allosteric regulation of SEC13 activity
Biosensors to monitor SEC13 conformational changes during COPII assembly
These technologies could help address key questions about how SEC13 serves as a master regulator coordinating information flow from the genome to the proteome . Particularly valuable would be approaches that can capture the dynamic nature of SEC13's multiple roles and elucidate how it integrates signals across different cellular compartments to maintain proteostasis.
Despite significant advances, several critical questions about SEC13's role in human cells remain unresolved:
Regulatory Mechanisms: How is SEC13 expression itself regulated, and how does this regulation respond to cellular stress or developmental cues? Understanding the control mechanisms would provide insight into how SEC13 functions as a master regulator coordinating information flow through various cellular compartments .
Functional Hierarchy: Given that different cellular processes show differential sensitivity to SEC13 levels , what determines this hierarchy? Is there a programmed order in which functions are preserved or sacrificed when SEC13 availability is limited?
Temporal Coordination: How does SEC13 achieve temporal coordination between its multiple roles? Does it cycle between different protein complexes, or can it simultaneously participate in multiple processes?
Disease Relevance: Beyond its established role in CFTR regulation , how does SEC13 contribute to other human diseases involving protein trafficking or quality control defects? Are there unrecognized conditions where SEC13 dysfunction plays a causal role?
Evolutionary Conservation: How conserved are SEC13's diverse functions across species, and what does this reveal about the evolutionary importance of coordinating information flow from genome to proteome?
Therapeutic Potential: Can SEC13-dependent pathways be safely modulated for therapeutic benefit without disrupting essential cellular functions? What determines the therapeutic window for such interventions?
Addressing these questions will require integrated approaches that combine structural biology, systems biology, and clinical research. The finding that SEC13 serves as an "unanticipated master regulator" suggests that continued research may reveal additional surprising functions and connections that could fundamentally change our understanding of cellular information processing.
Systems biology approaches offer powerful frameworks for understanding SEC13's integrative functions across cellular compartments:
Multi-scale Modeling:
Network Analysis:
Map the complete SEC13 interaction network across cellular compartments
Identify network motifs and feedback loops that enable SEC13's coordinating functions
Determine how information flows through SEC13-containing complexes
Quantitative Proteomics Approaches:
| Approach | Application to SEC13 Research | Expected Insights |
|---|---|---|
| Protein correlation profiling | Map SEC13 distribution across cellular compartments | Compartment-specific functions |
| Thermal proteome profiling | Detect SEC13-dependent protein stability changes | Effects on protein quality control |
| Pulse-SILAC | Measure SEC13's impact on protein turnover rates | Coordination of synthesis and degradation |
Integration of Multi-omics Data:
Combining transcriptomics, proteomics, and metabolomics data can reveal how SEC13 coordinates responses across different cellular processes. This integration is particularly relevant given SEC13's role in regulating information flow from genome to proteome .
Perturbation Response Analysis:
Systematic perturbation of SEC13 levels followed by comprehensive phenotypic profiling can help decipher the rules governing its master regulatory function. The observation that different processes show differential sensitivity to SEC13 levels provides a foundation for this approach.
By employing these systems biology approaches, researchers can move beyond understanding individual functions of SEC13 to comprehending how it serves as a master regulator that integrates and coordinates information flow across cellular compartments. This holistic perspective is essential for fully appreciating SEC13's role in maintaining cellular homeostasis and its potential as a therapeutic target.
SEC13 is a protein encoded by the SEC13 gene in humans. It belongs to the SEC13 family of WD-repeat proteins and is a crucial component of the endoplasmic reticulum and the nuclear pore complex . The protein has significant similarity to the yeast SEC13 protein, which is essential for vesicle biogenesis from the endoplasmic reticulum during protein transport .
SEC13 is involved in the formation of vesicles in the COPII complex, which includes other proteins such as Sec23p, Sec24p, Sar1p, and Sec31 . The COPII vesicle budding complex was initially described in the yeast system and was shown to provide coat proteins in the early secretory pathway . In humans, SEC13 plays a similar role in vesicle formation and transport.
The SEC13 protein is ubiquitously expressed and participates in various cellular processes, including mRNA transport, protein transport, and intracellular protein transport . It is also involved in the positive regulation of TOR signaling, sister chromatid cohesion, and the regulation of glycolytic processes . Additionally, SEC13 is a structural component of the nuclear pore complex, contributing to the transport of molecules between the nucleus and the cytoplasm .
Recombinant SEC13 is produced using recombinant DNA technology, which involves inserting the SEC13 gene into an expression system to produce the protein in vitro. This recombinant protein can be used in various research applications, including studies on vesicle formation, protein transport, and nuclear pore complex function.